Australia, New Zealand Consider Regulatory Reforms; PHARMAC To Add Sanofi Diabetes Agent Daonil: Australia, New Zealand Regulatory Roundup
This article was originally published in PharmAsia News
Executive Summary
PERTH, Australia - Australia's Therapeutic Goods Association announced it plans to implement a number of regulatory reforms that aim to update and streamline the existing framework for OTC and Rx products and medical devices
You may also be interested in...
Australia And New Zealand On Track For Joint Drug Agency And A Single Point Of Entry For Pharma
Ongoing efforts to create a single regulator for medicines and therapeutic products in Australia and New Zealand got a boost last week when the two governments jointly announced plans to create a new agency within five yeas
Australia And New Zealand On Track For Joint Drug Agency And A Single Point Of Entry For Pharma
Ongoing efforts to create a single regulator for medicines and therapeutic products in Australia and New Zealand got a boost last week when the two governments jointly announced plans to create a new agency within five yeas
Australia Department Of Innovation Releases 10-Year Plan On Pharma Strategy
PERTH, Australia - Australia's Minister for Innovation, Industry, Science and Research, Senator Kim Carr, has released a sweeping report that outlines a 10-year plan for the country's pharmaceutical and biotech industry